Cargando…
Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to Have a Significant Clinical Impact?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829637/ https://www.ncbi.nlm.nih.gov/pubmed/31373213 http://dx.doi.org/10.1177/1076029619866925 |
| _version_ | 1783465604019126272 |
|---|---|
| author | Ozgur Yurttas, Nurgul Eskazan, Ahmet Emre |
| author_facet | Ozgur Yurttas, Nurgul Eskazan, Ahmet Emre |
| author_sort | Ozgur Yurttas, Nurgul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6829637 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68296372019-11-07 Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to Have a Significant Clinical Impact? Ozgur Yurttas, Nurgul Eskazan, Ahmet Emre Clin Appl Thromb Hemost Editorial SAGE Publications 2019-08-02 /pmc/articles/PMC6829637/ /pubmed/31373213 http://dx.doi.org/10.1177/1076029619866925 Text en © The Author(s) 2019 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Editorial Ozgur Yurttas, Nurgul Eskazan, Ahmet Emre Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to Have a Significant Clinical Impact? |
| title | Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to
Have a Significant Clinical Impact? |
| title_full | Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to
Have a Significant Clinical Impact? |
| title_fullStr | Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to
Have a Significant Clinical Impact? |
| title_full_unstemmed | Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to
Have a Significant Clinical Impact? |
| title_short | Tyrosine Kinase Inhibitor–Associated Platelet Dysfunction: Does This Need to
Have a Significant Clinical Impact? |
| title_sort | tyrosine kinase inhibitor–associated platelet dysfunction: does this need to
have a significant clinical impact? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6829637/ https://www.ncbi.nlm.nih.gov/pubmed/31373213 http://dx.doi.org/10.1177/1076029619866925 |
| work_keys_str_mv | AT ozguryurttasnurgul tyrosinekinaseinhibitorassociatedplateletdysfunctiondoesthisneedtohaveasignificantclinicalimpact AT eskazanahmetemre tyrosinekinaseinhibitorassociatedplateletdysfunctiondoesthisneedtohaveasignificantclinicalimpact |